Comparable stake leader
BlackRock, Inc.
SEC ownership of EXELIXIS, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000939767.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
01 Jun 2026
- Public ticker
- EXEL on Nasdaq
- Parsed ownership sources
-
13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BlackRock, Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
01 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000939767
- Issuer location
- Alameda, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of EXELIXIS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
01 Jun 2026
13F
13D/G
3/4/5
Lead comparable stake: 10%
13D/G row: BlackRock, Inc.
Showing 1-8 of 50 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 10%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
10%
Farallon Capital Partners, L.P.
5.9%
AQR CAPITAL MANAGEMENT LLC
5.1%
VANGUARD CAPITAL MANAGEMENT LLC
5.1%
Michael Morrissey
1.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
10%
from 13D/G
|
$1,321,711,509
30,816,309 shares
|
— | 31 Mar 2026 |
| Farallon Capital Partners, L.P. |
13D/G
Dapice Joshua J.
|
5.9%
|
$650,216,205
15,709,500 shares
|
-$121,107,140 | 01 Jan 2026 |
| AQR CAPITAL MANAGEMENT LLC |
13D/G
13F
Company
|
5.1%
|
$601,788,575
13,658,388 shares
|
$0 | 31 Dec 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
5.1%
|
$567,573,964
13,233,247 shares
|
$0 | 31 Mar 2026 |
| Michael Morrissey |
3/4/5
President and CEO, Director
|
1.3%
|
$145,142,461
3,384,063 shares
|
— | 15 May 2026 |
| Stelios Papadopoulos |
3/4/5
Director
|
0.46%
|
$51,364,849
1,197,595 shares
|
-$4,355,000 | 27 May 2026 |
| Christopher J. Senner |
3/4/5
EVP and CFO
|
0.37%
|
$47,732,639
955,040 shares
|
-$4,556,048 | 15 May 2026 |
| Jeffrey Hessekiel |
3/4/5
EVP & General Counsel
|
0.27%
|
$32,059,538
694,395 shares
|
— | 15 May 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$40,528,598.
Buys
$1,187,235
Insiders: 1
Sells
$41,715,833
Insiders: 12
Net
-$40,528,598
Shares: -906,261
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 27,532
Shares: 933,793
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 219,170 | $0 | $10,620,641 | -$10,620,641 |
| 3-6 | 0 | 469,388 | $0 | $20,604,572 | -$20,604,572 |
| 6-9 | 27,532 | 245,235 | $1,187,235 | $10,490,619 | -$9,303,384 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 27 reporting-owner rows connected to EXELIXIS, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
27
Largest Forms 3/4/5 holder
Michael Morrissey
Net 12M change
-$40,528,597
Latest report
01 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Michael Morrissey | President and CEO, Director | $145,142,461 | Mixed | 15 May 2026 | ||
| David Edward Johnson | Director | $67,687,536 | +$1,187,235 | +1.8% | Mixed | 27 May 2026 |
| Stelios Papadopoulos | Director | $51,364,849 | -$4,355,000 | -7.8% | Mixed | 27 May 2026 |
| Christopher J. Senner | EVP and CFO | $47,732,639 | -$4,556,048 | -8.7% | Mixed | 15 May 2026 |
| Jeffrey Hessekiel | EVP & General Counsel | $32,059,538 | Mixed | 15 May 2025 | ||
| Dana Aftab | EVP, Research and Development | $30,195,472 | -$7,701,254 | -20% | Mixed | 26 May 2026 |
| Amy C. Peterson | EVP Prod Dev & Med Aff & CMO | $21,161,419 | Filing P/S | 15 May 2025 | ||
| Patrick J. Haley | EVP, Commercial | $17,813,948 | -$7,597,269 | -30% | Filing P/S | 20 May 2026 |
| Gisela Schwab | Pres, Prod Dev & Med Aff & CMO | $16,092,480 | Mixed | 26 Jul 2021 | ||
| Jack L. Wyszomierski | Director | $14,375,611 | -$4,580,660 | -24% | Filing P/S | 01 Jun 2026 |
| Peter Lamb | EVP, Scientific Strategy & CSO | $9,785,520 | Mixed | 15 Dec 2022 | ||
| Lance Willsey | Director | $9,702,127 | Mixed | 26 May 2022 | ||
| Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | $7,032,970 | Mixed | 03 Apr 2023 | ||
| Charles Cohen | Director | $5,975,033 | Mixed | 31 Dec 2021 | ||
| Brenda Hefti | SVP and General Counsel | $5,597,573 | -$1,154,264 | -17% | Mixed | 15 May 2026 |
| George Poste | Director | $5,455,565 | -$2,742,600 | -33% | Mixed | 27 May 2026 |
| Maria C. Freire | Director | $4,682,987 | -$949,164 | -17% | Mixed | 27 May 2026 |
| Tomas J. Heyman | Director | $2,172,335 | Mixed | 27 May 2026 | ||
| Marchesi Vincent T. | Director | $2,148,589 | Mixed | 26 May 2022 | ||
| Bob Oliver | Director | $1,264,697 | -$1,325,339 | -51% | Mixed | 27 May 2026 |
Recent insider transactions for EXELIXIS, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jack L. Wyszomierski | EXEL | Common Stock | Sale | -1.36% | $198,409 | $50.55 | -3,925 | 284,384 | 01 Jun 2026 | Direct |
| Sue Gail Eckhardt | EXEL | Common Stock | Sale | -37.9% | $491,974 | $50.14 | -9,812 | 16,079 | 01 Jun 2026 | Direct |
| Stelios Papadopoulos | EXEL | Common Stock | Award | 0.7% | 8,367 | 1,197,595 | 27 May 2026 | Direct | ||
| Tomas J. Heyman | EXEL | Common Stock | Award | 19.8% | 8,367 | 50,649 | 27 May 2026 | Direct | ||
| Sue Gail Eckhardt | EXEL | Common Stock | Award | 47.8% | 8,367 | 25,891 | 27 May 2026 | Direct | ||
| Julie Smith | EXEL | Common Stock | Award | 40.6% | 8,367 | 28,957 | 27 May 2026 | Direct | ||
| Maria C. Freire | EXEL | Common Stock | Award | 8.3% | 8,367 | 109,186 | 27 May 2026 | Direct | ||
| Mary C. Beckerle | EXEL | Common Stock | Award | 47.8% | 8,367 | 25,891 | 27 May 2026 | Direct | ||
| Bob Oliver | EXEL | Common Stock | Award | 39.6% | 8,367 | 29,487 | 27 May 2026 | Direct | ||
| Jack L. Wyszomierski | EXEL | Common Stock | Award | 2.99% | 8,367 | 288,309 | 27 May 2026 | Direct | ||
| George Poste | EXEL | Common Stock | Award | 7.04% | 8,367 | 127,199 | 27 May 2026 | Direct | ||
| Johnson David Edward | EXEL | Option (right to buy) | Award | 19,133 | 19,133 | 27 May 2026 | Direct | |||
| David Edward Johnson | EXEL | Option (right to buy) | Award | 19,133 | 19,133 | 27 May 2026 | Direct | |||
| Dana Aftab | EXEL | Common Stock | Sale | -6.81% | $2,187,758 | $50.35 | -43,451 | 594,741 | 26 May 2026 | Direct |
| Patrick J. Haley | EXEL | Common Stock | Sale | -8.24% | $1,599,399 | $49.81 | -32,110 | 357,638 | 20 May 2026 | Direct |
| Michael Morrissey | EXEL | Common Stock | Gift | 6.6% | 124,047 | 2,004,327 | 18 May 2026 | By Trust | ||
| Michael Morrissey | EXEL | Common Stock | Gift | -8.35% | -124,047 | 1,362,008 | 18 May 2026 | Direct | ||
| Christopher J. Senner | EXEL | Common Stock | Sale | -3.54% | $1,745,050 | $50.00 | -34,901 | 952,317 | 18 May 2026 | Direct |
| Brenda Hefti | EXEL | Common Stock | Sale | -5.84% | $332,641 | $50.21 | -6,625 | 106,762 | 18 May 2026 | Direct |
| Michael Morrissey | EXEL | Common Stock | Tax liability | -7.96% | -128,497 | 1,486,055 | 15 May 2026 | Direct | ||
| Christopher J. Senner | EXEL | Common Stock | Tax liability | -3.98% | -40,892 | 987,218 | 15 May 2026 | Direct | ||
| Patrick J. Haley | EXEL | Common Stock | Tax liability | -7.86% | -33,265 | 389,748 | 15 May 2026 | Direct | ||
| Brenda Hefti | EXEL | Common Stock | Tax liability | -5.35% | -6,411 | 113,387 | 15 May 2026 | Direct | ||
| Dana Aftab | EXEL | Common Stock | Tax liability | -4.57% | -30,578 | 638,192 | 15 May 2026 | Direct | ||
| Mary C. Beckerle | EXEL | Common Stock | Sale | -30.6% | $373,646 | $48.45 | -7,712 | 17,524 | 07 May 2026 | Direct |
| Mary C. Beckerle | EXEL | Common Stock | Options Exercise | 18% | 3,856 | 25,236 | 07 May 2026 | Direct | ||
| Mary C. Beckerle | EXEL | Option (right to buy) | Options Exercise | -23.1% | -3,856 | 12,854 | 07 May 2026 | Direct | ||
| Maria C. Freire | EXEL | Common Stock | Sale | -17% | $949,164 | $46.00 | -20,634 | 100,819 | 07 May 2026 | Direct |
| Maria C. Freire | EXEL | Common Stock | Options Exercise | 20.5% | 20,634 | 121,453 | 07 May 2026 | Direct | ||
| Maria C. Freire | EXEL | Option (right to buy) | Options Exercise | -100% | -20,634 | 0 | 07 May 2026 | Direct | ||
| George Poste | EXEL | Common Stock | Sale | -33.6% | $2,742,600 | $45.71 | -60,000 | 118,832 | 07 May 2026 | Direct |
| Michael Morrissey | EXEL | Common Stock | Gift | -5.51% | -109,676 | 1,880,280 | 06 May 2026 | By Trust | ||
| Dana Aftab | EXEL | Common Stock | Award | 8.44% | 52,018 | 668,124 | 26 Feb 2026 | Direct | ||
| Christopher J. Senner | EXEL | Common Stock | Award | 5.33% | 52,018 | 1,028,110 | 26 Feb 2026 | Direct | ||
| Brenda Hefti | EXEL | Common Stock | Award | 24% | 23,119 | 119,631 | 26 Feb 2026 | Direct | ||
| Patrick J. Haley | EXEL | Common Stock | Award | 10.6% | 40,459 | 422,367 | 26 Feb 2026 | Direct | ||
| Michael Morrissey | EXEL | Common Stock | Award | 11% | 160,437 | 1,614,552 | 26 Feb 2026 | Direct | ||
| Michael Morrissey | EXEL | Common Stock | Gift | -4.8% | -100,278 | 1,989,956 | 24 Feb 2026 | By Trust | ||
| Dana Aftab | EXEL | Common Stock | Sale | -7.22% | $2,132,351 | $44.50 | -47,918 | 616,106 | 24 Feb 2026 | Direct |
| Dana Aftab | EXEL | Common Stock | Sale | -4.31% | $1,324,868 | $44.35 | -29,873 | 664,024 | 19 Feb 2026 | Direct |
| Jack L. Wyszomierski | EXEL | Common Stock | Sale | -26.2% | $4,382,252 | $44.01 | -99,574 | 279,942 | 18 Feb 2026 | Direct |
| Jack L. Wyszomierski | EXEL | Common Stock | Options Exercise | 5.75% | 20,634 | 379,516 | 18 Feb 2026 | Direct | ||
| Jack L. Wyszomierski | EXEL | Option (right to buy) | Options Exercise | -100% | -20,634 | 0 | 18 Feb 2026 | Direct | ||
| Julie Smith | EXEL | Common Stock | Sale | -75.7% | $2,849,200 | $44.44 | -64,117 | 20,590 | 18 Feb 2026 | Direct |
| Julie Smith | EXEL | Common Stock | Options Exercise | 11449.5% | 64,117 | 64,677 | 18 Feb 2026 | Direct | ||
| Julie Smith | EXEL | Option (right to buy) | Options Exercise | -100% | -64,117 | 0 | 18 Feb 2026 | Direct | ||
| Michael Morrissey | EXEL | Common Stock | Gift | 6.37% | 125,094 | 2,090,234 | 18 Feb 2026 | By Trust | ||
| Michael Morrissey | EXEL | Common Stock | Gift | -7.92% | -125,094 | 1,454,115 | 18 Feb 2026 | Direct | ||
| Brenda Hefti | EXEL | Common Stock | Sale | -16.2% | $821,623 | $44.01 | -18,669 | 96,512 | 18 Feb 2026 | Direct |
| Julie Smith | EXEL | Common Stock | Sale | -67.3% | $1,838,145 | $43.33 | -42,422 | 20,590 | 17 Feb 2026 | Direct |
* marks a reported price that did not pass the local price check.